Skip to main content

Table 3 Different vaccine administration routes: intradermal vs. subcutaneous lymph node uptake

From: Evaluation of in vivo labelled dendritic cell migration in cancer patients

Patients mDC × 106 Administration route Isotope Max uptake (%) *
R.L. (no. 7) 4 Intradermal 99m Tc-HMPAO 0.95
G.D. (no. 8) 4 Intradermal 99m Tc-HMPAO 1.02
R.L. (no. 7) 4 Subcutaneous 99m Tc-HMPAO 0.30
G.D. (no. 8) 4 Subcutaneous 99m Tc-HMPAO 0.37
  1. UPTAKE RATIO: intradermal/subcutaneous average: 3 *Maximum uptake = maximum lymph node activity/inoculation site activity at 0 h